Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicorette Icy White 2mg medicated chewing gum
0410020B0BBAWBA
|
Nicorette | Nicotine | Central Nervous System | 781 |
|
Nicotinell TTS 10 patches
0410020B0BCAAAP
|
Nicotinell | Nicotine | Central Nervous System | 730 |
|
Nicorette Freshmint 2mg medicated chewing gum
0410020B0BBAPBA
|
Nicorette | Nicotine | Central Nervous System | 669 |
|
Nicotine 500micrograms/dose nasal spray
0410020B0AAANAN
|
Nicotine | Nicotine | Central Nervous System | 664 |
|
NiQuitin 7mg patches
0410020B0BDACAP
|
NiQuitin | Nicotine | Central Nervous System | 546 |
|
NiQuitin Minis Mint 4mg lozenges
0410020B0BDANAZ
|
NiQuitin | Nicotine | Central Nervous System | 543 |
|
Nicorette Freshmint 4mg medicated chewing gum
0410020B0BBAQBD
|
Nicorette | Nicotine | Central Nervous System | 541 |
|
Nicorette Cools 4mg lozenges
0410020B0BBBCAZ
|
Nicorette | Nicotine | Central Nervous System | 494 |
|
Nicorette Fruitfusion 2mg medicated chewing gum
0410020B0BBARBA
|
Nicorette | Nicotine | Central Nervous System | 493 |
|
NiQuitin Clear 7mg patches
0410020B0BDAFAP
|
NiQuitin | Nicotine | Central Nervous System | 493 |
|
Nicorette Icy White 4mg medicated chewing gum
0410020B0BBAXBD
|
Nicorette | Nicotine | Central Nervous System | 423 |
|
Nicotine 2mg sublingual tablets sugar free
0410020B0AAAWAW
|
Nicotine | Nicotine | Central Nervous System | 419 |
|
Nicorette Fruitfusion 4mg medicated chewing gum
0410020B0BBASBD
|
Nicorette | Nicotine | Central Nervous System | 378 |
|
NiQuitin Minis Mint 1.5mg lozenges
0410020B0BDAPBP
|
NiQuitin | Nicotine | Central Nervous System | 360 |
|
Nicorette Microtab 2mg sublingual tablets
0410020B0BBAHAW
|
Nicorette | Nicotine | Central Nervous System | 334 |
|
Nicorette 500micrograms/dose nasal spray
0410020B0BBAFAN
|
Nicorette | Nicotine | Central Nervous System | 305 |
|
NiQuitin Minis Mint 2mg lozenges
0410020B0BDAWAY
|
NiQuitin | Nicotine | Central Nervous System | 275 |
|
Nicotine 1.5mg lozenges sugar free
0410020B0AABPBP
|
Nicotine | Nicotine | Central Nervous System | 231 |
|
Nicotinell Mint 2mg medicated chewing gum
0410020B0BCAEBA
|
Nicotinell | Nicotine | Central Nervous System | 227 |
|
Nicotinell Fruit 2mg medicated chewing gum
0410020B0BCAFBA
|
Nicotinell | Nicotine | Central Nervous System | 199 |
|
Nicorette Original 4mg medicated chewing gum
0410020B0BBABBD
|
Nicorette | Nicotine | Central Nervous System | 159 |
|
Nicotinell Fruit 4mg medicated chewing gum
0410020B0BCAHBD
|
Nicotinell | Nicotine | Central Nervous System | 154 |
|
NiQuitin Mint 2mg lozenges
0410020B0BDAKAY
|
NiQuitin | Nicotine | Central Nervous System | 154 |
|
Nicorette Original 2mg medicated chewing gum
0410020B0BBAABA
|
Nicorette | Nicotine | Central Nervous System | 151 |
|
NiQuitin Mint 4mg lozenges
0410020B0BDALAZ
|
NiQuitin | Nicotine | Central Nervous System | 147 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.